Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Olema Pharmaceuticals Inc
(NQ:
OLMA
)
11.80
+0.25 (+2.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Olema Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies
December 05, 2023
From
Olema Oncology
Via
GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 04, 2023
From
Olema Oncology
Via
GlobeNewswire
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/28
November 28, 2023
Via
Investor Brand Network
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/13
November 13, 2023
Via
Investor Brand Network
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/9
November 09, 2023
Via
Investor Brand Network
Olema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS)
November 28, 2023
From
Olema Oncology
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 27, 2023
Via
Benzinga
Olema Stock Has Soared 551% This Year. Its CEO Thinks It's Still Undervalued.
November 22, 2023
The company is working on treatments for breast cancer in a market worth $15 billion, according to the CEO.
Via
Investor's Business Daily
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/8
November 08, 2023
Via
Investor Brand Network
Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update
November 07, 2023
From
Olema Oncology
Via
GlobeNewswire
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/7
November 07, 2023
Via
Investor Brand Network
TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday
November 06, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 02, 2023
From
Olema Oncology
Via
GlobeNewswire
Olema Oncology to Participate in Upcoming Investor Conferences in November
November 01, 2023
From
Olema Oncology
Via
GlobeNewswire
Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 10/16
October 16, 2023
Via
Investor Brand Network
Analyst Ratings for Olema Pharmaceuticals
October 11, 2023
Via
Benzinga
Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
October 22, 2023
From
Olema Oncology
Via
GlobeNewswire
Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday
October 17, 2023
U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors
October 17, 2023
Mr. Garland brings significant industry expertise with a long track record of successful launches
From
Olema Oncology
Via
GlobeNewswire
Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress
October 16, 2023
From
Olema Oncology
Via
GlobeNewswire
Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity
October 12, 2023
Preclinical data to be presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
From
Olema Oncology
Via
GlobeNewswire
Olema Oncology Announces Expansion of Collaboration Agreement with Novartis
October 10, 2023
From
Olema Oncology
Via
GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2023
From
Olema Oncology
Via
GlobeNewswire
7 ‘Strong Buy’ Biotech Stocks to Rejuvenate Your Portfolio
September 27, 2023
Dive into these seven strong buy biotech stocks, handpicked by Wall Street, to inject vigor into your investment game.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
September 21, 2023
Via
Benzinga
Olema Oncology Announces New Preclinical KAT6 Inhibitor Data to be Presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
September 20, 2023
From
Olema Oncology
Via
GlobeNewswire
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
The 7 Best Small-Cap Stocks to Buy Now: September 2023
September 07, 2023
Although even the best small-cap stocks to buy can be incredibly dangerous, these ideas may offer some rationality behind them.
Via
InvestorPlace
Olema Oncology to Participate in Upcoming Investor Conferences
September 06, 2023
From
Olema Oncology
Via
GlobeNewswire
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 05, 2023
From
Olema Oncology
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.